1034.5000 -2.40 (-0.23%)
NSE Sep 16, 2025 15:31 PM
Volume: 511.7K
 

1034.50
-0.23%
Karvy
Profits aided by better margins: Cadila's revenues decreased by 8.1% on a YoY basis to Rs 29.6bn (our estimateof Rs 29.8 bn) during the quarter. Operating margins increased to 23.2% (higher than our estimates of 21.1%) compared to 26.5% in Q2FY19 due to lower revenues, higher staff cost and other expenses.
Zydus Lifesciences L.. has an average target of 1045.33 from 6 brokers.
More from Zydus Lifesciences Ltd.
Recommended